DIAMEDICA THERAPEUTICS INC.

Profile

Company Names

DIAMEDICA THERAPEUTICS INC.

Addresses

301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN 55305

TWO CARLSON PARKWAY, SUITE 260, MINNEAPOLIS, MN 55447

2 CARLSON PARKWAY, SUITE 260, MINNEAPOLIS, MN 55447

Phone Numbers

(763) 312-6755
(763) 496-5454

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$110,387,718.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-07-23 
$30,100,000.00 
$30,100,000.00 
$0.00 
Equity 
5
2024-06-28 
$11,800,000.00 
$11,800,000.00 
$0.00 
Equity 
4
2023-06-23 
$37,536,853.00 
$37,536,853.00 
$0.00 
Equity 
3
2023-04-10 
$750,000.00 
$750,000.00 
$0.00 
Equity 
2
2021-09-28 
$29,999,995.00 
$29,999,995.00 
$0.00 
Equity 
1
2018-03-29 
$200,870.00 
$344,348.00 
$143,478.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HARRY 
W. 
ALCORN JR. 
EXECUTIVE OFFICER
AMY 
L. 
BURROUGHS 
DIRECTOR
DOMINIC 
 
CUNDARI 
EXECUTIVE OFFICER
JULIE 
 
DAVES 
EXECUTIVE OFFICER
SYDNEY 
 
GILMAN 
EXECUTIVE OFFICER
MICHAEL 
 
GIUFFRE 
DIRECTOR
MICHAEL 
R. 
GIUFFRE 
DIRECTOR
R. 
MICHAEL 
GIUFFRE 
DIRECTOR
KIRSTEN 
 
GRUIS 
EXECUTIVE OFFICER
DAVID 
 
GURVEY 
EXECUTIVE OFFICER
SCOTT 
 
KELLEN 
EXECUTIVE OFFICER
TANYA 
N. 
LEWIS 
DIRECTOR
LORIANNE 
 
MASUOKA 
EXECUTIVE OFFICER
PAUL 
 
PAPI 
EXECUTIVE OFFICER
JAMES 
T. 
PARSONS 
DIRECTOR
RICK 
 
PAULS 
EXECUTIVE OFFICER, DIRECTOR
RICHARD 
 
PILNIK 
DIRECTOR
RICHARD 
D. 
PILNIK 
DIRECTOR
CHARLES 
P. 
SEMBA 
DIRECTOR
TODD 
 
VERDOORN 
EXECUTIVE OFFICER
DAVID 
J. 
WAMBEKE 
EXECUTIVE OFFICER
ZHENYU 
(JERRY) 
XIAO 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-23 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-23 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-28 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CRAIG-HALLUM CAPITAL GROUP LLC